Network and Data Integration for Biomarker Signature Discovery via Network Smoothed T-Statistics
暂无分享,去创建一个
[1] J. Rivas,et al. Deregulation of microRNA expression in the different genetic subtypes of multiple myeloma and correlation with gene expression profiling , 2010, Leukemia.
[2] R. Tibshirani,et al. Diagnosis of multiple cancer types by shrunken centroids of gene expression , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[3] S. Pileri,et al. Retinoblastoma (RB1) gene product expression in breast carcinoma. Correlation with Ki-67 growth fraction and biopathological profile. , 1998, Journal of clinical pathology.
[4] R. Tibshirani,et al. Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[5] J. Clement,et al. Expression of bone morphogenetic protein 6 in normal mammary tissue and breast cancer cell lines and its regulation by epidermal growth factor , 1999, International journal of cancer.
[6] Louise R Howe,et al. Wnt Signaling and Breast Cancer , 2004, Cancer biology & therapy.
[7] Min Zhu,et al. Integrated miRNA and mRNA expression profiling of mouse mammary tumor models identifies miRNA signatures associated with mammary tumor lineage , 2011, Genome Biology.
[8] Holger Fröhlich,et al. Integration of pathway knowledge into a reweighted recursive feature elimination approach for risk stratification of cancer patients , 2010, Bioinform..
[9] Gary D. Bader,et al. Pathway Commons, a web resource for biological pathway data , 2010, Nucleic Acids Res..
[10] B. Ponder,et al. Allele loss from large regions of chromosome 17 is common only in certain histological subtypes of ovarian carcinomas. , 1996, British Journal of Cancer.
[11] S. Brewster,et al. THE Wnt SIGNALLING PATHWAY IS A POTENTIAL THERAPEUTIC TARGET IN PROSTATE CANCER , 2006, BJU international.
[12] G. Mills,et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth , 2011, Nature Medicine.
[13] Emmanuel Barillot,et al. Classification of microarray data using gene networks , 2007, BMC Bioinformatics.
[14] Benjamin J. Raphael,et al. Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.
[15] Klaus Obermayer,et al. A new summarization method for affymetrix probe level data , 2006, Bioinform..
[16] W. Vogel,et al. (CAG)nCAA and GGN repeats in the human androgen receptor gene are not associated with prostate cancer in a French–German population , 1999, European Journal of Human Genetics.
[17] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[18] J. Varley,et al. Frequent alterations of cell cycle regulators in early-stage breast lesions as detected by immunohistochemistry. , 1998, British Journal of Cancer.
[19] Jelle J. Goeman,et al. A global test for groups of genes: testing association with a clinical outcome , 2004, Bioinform..
[20] John D. Osborne,et al. Annotating the human genome with Disease , 2009 .
[21] W. Kibbe,et al. Annotating the human genome with Disease Ontology , 2009, BMC Genomics.
[22] Stijn van Dongen,et al. miRBase: tools for microRNA genomics , 2007, Nucleic Acids Res..
[23] Stefan Wiemann,et al. KEGGgraph: a graph approach to KEGG PATHWAY in R and bioconductor , 2009, Bioinform..
[24] Pedro Larrañaga,et al. A review of feature selection techniques in bioinformatics , 2007, Bioinform..
[25] Y. Moreau,et al. Computational tools for prioritizing candidate genes: boosting disease gene discovery , 2012, Nature Reviews Genetics.
[26] Thomas Lengauer,et al. ROCR: visualizing classifier performance in R , 2005, Bioinform..
[27] Holger Fröhlich,et al. pathClass: an R-package for integration of pathway knowledge into support vector machines for biomarker discovery , 2011, Bioinform..
[28] David Warde-Farley,et al. Dynamic modularity in protein interaction networks predicts breast cancer outcome , 2009, Nature Biotechnology.
[29] I. Van der Auwera,et al. Integrated miRNA and mRNA expression profiling of the inflammatory breast cancer subtype , 2010, British Journal of Cancer.
[30] S. Brewster,et al. Wnt signalling and prostate cancer , 2005, Prostate Cancer and Prostatic Diseases.
[31] Gary D Bader,et al. International network of cancer genome projects , 2010, Nature.
[32] Fan Chung,et al. The heat kernel as the pagerank of a graph , 2007, Proceedings of the National Academy of Sciences.
[33] D. Prowse,et al. Cancer Cell International Inhibition of Androgen-independent Prostate Cancer Cell Growth Is Enhanced by Combination Therapy Targeting Hedgehog and Erbb Signalling , 2008 .
[34] R. Kudo,et al. Telomerase activity in malignant ovarian tumors with deregulation of cell cycle regulatory proteins. , 1999, Cancer letters.
[35] Alexander J. Smola,et al. Learning with kernels , 1998 .
[36] Aixia Guo,et al. Gene Selection for Cancer Classification using Support Vector Machines , 2014 .
[37] Eric R. Ziegel,et al. The Elements of Statistical Learning , 2003, Technometrics.
[38] Michael Schroeder,et al. Google Goes Cancer: Improving Outcome Prediction for Cancer Patients by Network-Based Ranking of Marker Genes , 2012, PLoS Comput. Biol..
[39] Holger Fröhlich,et al. Prognostic gene signatures for patient stratification in breast cancer - accuracy, stability and interpretability of gene selection approaches using prior knowledge on protein-protein interactions , 2012, BMC Bioinformatics.
[40] Holger Fröhlich,et al. Review Biomarker Gene Signature Discovery Integrating Network Knowledge , 2012 .
[41] Alexandre P. Francisco,et al. Interactogeneous: Disease Gene Prioritization Using Heterogeneous Networks and Full Topology Scores , 2012, PloS one.
[42] Tijl De Bie,et al. Kernel-based data fusion for gene prioritization , 2007, ISMB/ECCB.
[43] Desmond J. Higham,et al. GeneRank: Using search engine technology for the analysis of microarray experiments , 2005, BMC Bioinformatics.
[44] Leo Breiman,et al. Random Forests , 2001, Machine Learning.
[45] Jing Ma,et al. Immunohistochemical expression of BRCA1 and lethal prostate cancer. , 2010, Cancer research.
[46] Mary J. C. Hendrix,et al. ErbB/EGF Signaling and EMT in Mammary Development and Breast Cancer , 2010, Journal of Mammary Gland Biology and Neoplasia.
[47] Yixin Chen,et al. Graph ranking for exploratory gene data analysis , 2009, BMC Bioinformatics.
[48] Mithat Gönen,et al. Statistical aspects of gene signatures and molecular targets. , 2009, Gastrointestinal cancer research : GCR.
[49] Sayan Mukherjee,et al. Choosing Multiple Parameters for Support Vector Machines , 2002, Machine Learning.
[50] Tim Beißbarth,et al. Graph based fusion of miRNA and mRNA expression data improves clinical outcome prediction in prostate cancer , 2011, BMC Bioinformatics.
[51] Harald Binder,et al. Incorporating pathway information into boosting estimation of high-dimensional risk prediction models , 2009, BMC Bioinformatics.
[52] Michalis E. Blazadonakis,et al. Complementary Gene Signature Integration in Multiplatform Microarray Experiments , 2011, IEEE Transactions on Information Technology in Biomedicine.
[53] W. Gerald,et al. Targeting AKT/mTOR and ERK MAPK signaling inhibits hormone-refractory prostate cancer in a preclinical mouse model. , 2008, The Journal of clinical investigation.
[54] Wei Pan,et al. Network-based support vector machine for classification of microarray samples , 2009, BMC Bioinformatics.
[55] M. Provencio,et al. Detection of loss of heterozygosity at RAD51, RAD52, RAD54 and BRCA1 and BRCA2 loci in breast cancer: pathological correlations , 1999 .
[56] H. Kölbl,et al. The humoral immune system has a key prognostic impact in node-negative breast cancer. , 2008, Cancer research.
[57] Lincoln D. Stein,et al. Cancer genomics: technology, discovery, and translation. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[58] A. Cress,et al. Inhibition of p38-MAPK signaling pathway attenuates breast cancer induced bone pain and disease progression in a murine model of cancer-induced bone pain , 2011, Molecular pain.
[59] Qing Wang,et al. Towards precise classification of cancers based on robust gene functional expression profiles , 2005, BMC Bioinformatics.
[60] Vasyl Pihur,et al. RankAggreg, an R package for weighted rank aggregation , 2009, BMC Bioinformatics.
[61] A. Sivachenko,et al. Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer , 2012, Nature Genetics.
[62] Yoshihiro Yamanishi,et al. KEGG for linking genomes to life and the environment , 2007, Nucleic Acids Res..
[63] L. Chin,et al. Making sense of cancer genomic data. , 2011, Genes & development.
[64] T. Ideker,et al. Network-based classification of breast cancer metastasis , 2007, Molecular systems biology.
[65] Lodewyk F. A. Wessels,et al. A Critical Evaluation of Network and Pathway-Based Classifiers for Outcome Prediction in Breast Cancer , 2011, PloS one.
[66] Doheon Lee,et al. Inferring Pathway Activity toward Precise Disease Classification , 2008, PLoS Comput. Biol..
[67] Steve Goodison,et al. Optimizing molecular signatures for predicting prostate cancer recurrence , 2009, The Prostate.
[68] C. Sander,et al. Integrative genomic profiling of human prostate cancer. , 2010, Cancer cell.